Translation & the Genetic Code
Codons, the A-P-E ribosome, and why antibiotics spare your ribosomes
The genetic code
Core features. The code is read in triplets (3 bases per codon) and is:
- Degenerate/redundant — most amino acids are specified by more than one codon.
- Unambiguous — each codon specifies only one amino acid.
- Commaless and nonoverlapping — read continuously from a fixed start, each base used once.
- Nearly universal — shared by almost all organisms.
Degenerate is not ambiguous: many codons can map to one amino acid, but each codon still means only one.
Start codon. AUG marks translation initiation and codes methionine — N-formylmethionine (fMet) in bacteria, plain methionine in eukaryotes. Memory aid: AUG in-AUG-urates protein synthesis.
Stop codons. UGA, UAA, and UAG terminate translation. They are recognized by release factors, not by any tRNA. Mnemonic: U Go Away, U Are Away, U Are Gone.
Wobble. The first two codon bases pair strictly with the anticodon, but the third (3') position pairs loosely, so one tRNA can read several codons. This is why most of the code's degeneracy sits in the third position — and why many third-base changes are silent (GAA and GAG both code glutamate).
Ribosomes, tRNA, and the steps of translation
Ribosome sizes. Eukaryotic ribosomes are 40S + 60S = 80S; prokaryotic ribosomes are 30S + 50S = 70S. Mnemonic: Even numbers (40, 60, 80) for Eukaryotes. This structural difference is the basis for antibiotic selectivity.
Charging tRNA — the fidelity checkpoint. Each aminoacyl-tRNA synthetase (one per amino acid) uses ATP to attach its amino acid to the 3' CCA end of the matching tRNA, proofreading the match. The ribosome checks only codon–anticodon pairing, not the amino acid, so a mischarged tRNA inserts the wrong residue; charging is therefore the accuracy checkpoint of translation.
A, P, and E sites. The A (aminoacyl) site receives the incoming charged tRNA, the P (peptidyl) site holds the tRNA carrying the growing chain, and the E site is where the uncharged tRNA exits. Peptidyl transferase — a ribozyme made of large-subunit rRNA, not protein — forms each peptide bond. Mnemonic: APE (Aminoacyl → Peptidyl → Exit).
- ChargingSynthetase + ATP loads the amino acid onto tRNA
- InitiationSmall subunit and initiator tRNA find AUG; large subunit joins (GTP)
- A site entryIncoming aminoacyl-tRNA pairs with the next codon (GTP)
- Peptide bondPeptidyl transferase (rRNA ribozyme) transfers the chain to the new amino acid
- TranslocationRibosome shifts one codon toward the 3' end (GTP); tRNAs move A → P → E
- TerminationRelease factor recognizes the stop codon; the polypeptide is released
Direction and energy. mRNA is read 5'→3' and the protein grows from N-terminus to C-terminus. Charging uses ATP; aminoacyl-tRNA delivery and translocation during elongation use GTP.
Ribosome-targeting antibiotics
30S inhibitors. Aminoglycosides (e.g., gentamicin) block the initiation complex and cause misreading of mRNA; they are bactericidal. Tetracyclines block aminoacyl-tRNA from entering the A site and are bacteriostatic. Mnemonic: buy AT 30 (Aminoglycosides, Tetracyclines).
50S inhibitors. Macrolides such as erythromycin bind the 23S rRNA and block translocation; chloramphenicol blocks peptidyl transferase; clindamycin and linezolid also act on the 50S subunit. Mnemonic: CCEL at 50 (Chloramphenicol, Clindamycin, Erythromycin/macrolides, Linezolid). Most are bacteriostatic.
| Drug class | Subunit | Mechanism | Classic toxicity |
|---|---|---|---|
| Aminoglycosides | 30S | Block initiation, cause misreading (bactericidal) | Nephrotoxicity, ototoxicity, neuromuscular blockade |
| Tetracyclines | 30S | Block aminoacyl-tRNA entry to A site | Tooth discoloration and impaired bone growth in children, photosensitivity |
| Macrolides | 50S | Bind 23S rRNA, block translocation | GI dysmotility, QT prolongation |
| Chloramphenicol | 50S | Blocks peptidyl transferase | Aplastic anemia, gray baby syndrome |
| Clindamycin | 50S | Blocks peptide transfer (translocation) | C. difficile colitis |
| Linezolid | 50S | Prevents initiation complex formation | Myelosuppression, serotonin syndrome |
Selective toxicity — and its limits. Bacterial 70S ribosomes differ from human 80S ribosomes, which is why these drugs spare our cytoplasmic protein synthesis. Human mitochondrial ribosomes, however, resemble bacterial ones, which helps explain linezolid myelosuppression and aminoglycoside ototoxicity.
Toxins that hit human translation. Diphtheria toxin and Pseudomonas exotoxin A inactivate elongation factor 2 (EF-2) by ADP-ribosylation; Shiga toxin and ricin inactivate the 60S subunit by damaging its rRNA.
Post-translational modification
Trimming. Proteolytic removal of segments activates many proteins; proinsulin is cleaved to insulin, releasing C-peptide. Because C-peptide is secreted only with endogenous insulin, it confirms endogenous production — high in insulinoma or sulfonylurea use, low after injected insulin.
Covalent additions. Phosphorylation, glycosylation (including the mannose-6-phosphate tag that routes enzymes to lysosomes), hydroxylation (proline and lysine residues of collagen, vitamin C–dependent), and vitamin K–dependent γ-carboxylation of clotting factors (II, VII, IX, X, protein C, protein S).
Ubiquitination. Attaching ubiquitin marks a protein for degradation by the proteasome. Chaperone proteins assist correct folding.
Mutation types
| Type | Change | Effect | Example |
|---|---|---|---|
| Silent | Base change, same amino acid | Usually none; often a third-base (wobble) change | GAA → GAG (both glutamate) |
| Missense | Base change, different amino acid | Variable; altered protein | Sickle cell (glutamate → valine in β-globin) |
| Nonsense | Base change creates a stop codon | Early stop, truncated protein | Some β⁰-thalassemia alleles |
| Frameshift | Insertion/deletion not a multiple of 3 | All downstream codons garbled | Duchenne muscular dystrophy, Tay-Sachs |
Duchenne vs Becker. An out-of-frame (frameshift) deletion in the dystrophin gene yields no functional dystrophin and severe Duchenne muscular dystrophy; an in-frame deletion (a multiple of 3) yields a shortened, partly functional protein and milder Becker muscular dystrophy.
A single-base insertion or deletion in a coding region is a frameshift until proven otherwise; an indel of 3 bases keeps the frame and removes or adds one amino acid (e.g., the CFTR ΔF508 deletion).